Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Dari data SIRS,2010 pasien kanker payudara terbanyak di rawat inap maupun rawat jalan di seluruh RS di Indonesia yakni 28,7 dari seluruh kanker. Efek samping kemoterapi dapat menurunkan kapasitas fungsional dan kualitas hidup pasien. Tujuan penelitian ini untuk mengetahui dampak pengobatan kemoterapi terhadap perubahan kapasitas fungsional dan kualitas hidup pasien kanker payudara stadium I sampai III. Metode: Desain pre dan post-test. Data diambil sebelum subjek mendapat protokol kemoterapi pertama dan setelah kemoterapi adjuvant ke-3. Kapasitas fungsional dinilai dengan uji jalan 6 menit dan kualitas hidup dinilai dengan EORTC QLQ C-30. Penelitian pada 30 subjek yang didapat secara konsekutif dan memenuhi kriteria penelitian. Data demografis dan klinis pasien dikumpulkan dan dicatat. Hasil: Dari 30 subjek, terdapat 26 subjek 86,7 mengalami penurunan rerata score uji jalan 6 menit setelah kemoterapi adjuvant ke-3 dibandingkan sebelum pengobatan kemoterapi. Terdapat perbedaan yang bermakna dengan nilai p le;0,05. Hasil score EORTC QLQ C-30 pada domain skala fungsi dan kualitas hidup secara global, didapatkan score rerata yang menurun pada semua fungsi setelah kemoterapi adjuvant ke-3 dibandingkan sebelum kemoterapi pada semua subjek. Perbedaan bermakna terdapat pada skala fungsi sosial p le;0,05 . Pada skala gejala terdapat peningkatan rerata score tiap gejala setelah kemoterapi adjuvant ke-3 dibandingkan sebelum kemoterapi pada semua subjek. Perbedaan bermakna terdapat pada gejala fatique, mual-muntah, dan penurunan nafsu makan p le;0,05. Kesimpulan: Terdapat penurunan kapasitas fungsional dan kualitas hidup pada pasien kanker payudara setelah mendapat kemoterapi adjuvant ke-3 akibat efek samping pengobatan kemoterapi.

---

Background: SIRS data from 2010 breast cancer patients most in inpatient and outpatient care in all hospitals in Indonesia, namely 28.7 of all cancers. The side effects of chemotherapy can decrease the functional capacity and quality of life of patients. The purpose of this study Identify the impact of chemotherapy treatment in functional capacity and quality of life in patients with stage I III breast cancer.

Methods: Pre and post test design. Data was taken before the subject had the first chemotherapy protocols and after third adjuvant chemotherapy. Functional capacity was assessed with the 6 minute walking test and quality of life was assessed with the EORTC QLQ C 30. This study was conducted on 30 subjects with consecutive sampling and met the criteria of this study. Demographic and clinical patient data were collected and recorded.

Results: Among 30 subjects, 26 subjects 86.7 experienced decline in six minute walking test score after third adjuvant chemotherapy compare to prior chemotherapy treatment. There were significant differences in functional capacity before and after third chemotherapy adjuvant p le 0,05. There were decrease in mean score of all functions in EORTC QLQ C 30 score on functional domain scale and global quality of life in all subject after third adjuvant chemotherapy compared to prior chemotherapy treatment. Significant differences was found in social functioning scale p le 0,05 . On symptoms scale, there were increase in average score of each symptoms after third adjuvant chemotherapy in all subject compare to prior chemotherapy treatment. Significant differences was found in symptoms of fatigue, nausea, vomiting, and decreased appetite p le 0,05.

Conclusion: There are decrease in functional capacity and quality of life in breast cancer patients after third adjuvant chemotherapy due to side effects of chemotherapy treatment."

"Kanker payudara merupakan jenis keganasan tersering pada wanita di Indonesia. Kemoterapi dan inaktivitas fisik selama pengobatan kanker menyebabkan penurunan kapasitas fungsional dan kualitas hidup. Rehabilitasi preventif dengan latihan aerobik terbukti bermanfaat meningkatkan kapasitas fungsional dan kualitas hidup pada populasi ini, namun studi mengenai aktivitas berjalan kaki terukur pedometer masih belum diteliti di Indonesia. Studi ini bertujuan menilai efek aktivitas berjalan kaki harian 4000 langkah selama 8 minggu terhadap kapasitas fungsional dan kualitas hidup pasien kanker payudara stadium II-III yang menjalani kemoterapi. Studi ini adalah one group pre and post test design, dilakukan pada 15 subjek, berusia 25-59 tahun, di poliklinik Rumah Sakit Kanker Dharmais. Kapasitas fungsional ditentukan dari jarak tempuh uji jalan enam menit protokol Nury dan kualitas hidup dengan EORTC-QLQ-C30 versi Bahasa Indonesia, yang dinilai sebelum dan setelah rehabilitasi preventif. Rerata capaian jumlah langkah harian adalah 5005,26+1574 langkah. Tidak ditemukan perbedaan kapasitas fungsional sebelum dan setelah rehabilitasi (436,84±47,87 dan 449,64±51,84, p=0,0143). Terjadi peningkatan kualitas hidup global EORTC QLQ-C30 setelah penerapan aktivitas berjalan kaki terukur (63,89±30,97 dan 82,78±14,24, p=0,011). Aktivitas berjalan kaki terukur pedometer selama 8 minggu mempertahankan kapasitas fungsional dan meningkatkan kualitas hidup pada pasien kanker payudara stadium II-III yang menjalani kemoterapi.

---

Breast cancer is the most common cancer amongst Indonesian women. Chemotherapy and physical inactivity during cancer treatment lead to decreased functional capacity and quality of life, which could be prevented by doing aerobic exercise. However, studies on pedometer-based walking activity programs have not been studied in Indonesia. This study aimed to assess the effects of eight weeks of 4000-steps of the pedometer-based walking activity program on functional capacity and quality of life in stage II-III breast cancer patients receiving chemotherapy. This study was a one-group pre-and post-test design with 15 subjects, aged 25-59 years, in the outpatient of Rumah Sakit Kanker Dharmais. The functional capacity was determined from the six-minute walk test distances of the Nury's protocol and quality of life with the EORTC-QLQ-C30 Indonesian version, which were assessed before and after rehabilitation. The average daily step count was 5005.26+1574 steps. There was no difference in functional capacity before and after rehabilitation (436.84±47.87 and 449.64±51.84, p=0.0143). There was an increase in the global quality of life of the EORTC QLQ-C30 after the implementation of measured walking activities (63.89±30.97 and 82.78±14.24, p=0.011). Eight weeks of pedometer-based walking activity program maintains functional capacity and improves the quality of life in stage II-III breast cancer patients receiving chemotherapy."

"Pendahuluan: Kualitas hidup pasien dengan kanker kolorektal di Indonesia saat ini dievaluasi oleh kuesioner yang tidak seragam. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire ColoRectal 29 EORTC QLQ-CR29 , adalah sebuah kuesioner yang terstandarisasi untuk menilai kualitas hidup yang umum digunakan pada negara maju. Penelitian ini untuk membuktikan bahwa EORTC QLQ-CR29 adalah kuesioner yang valid dan reliabel untuk digunakan di Indonesia. Metode: Kuesiober EORTC QLQ-CR29 diterjemahkan kedalam bahasa Indonesia, dan diterjemahkan kembali ke bahasa Inggris. Dilakukan sebuah studi pilot terlebih dahulu, kemudian studi utama ke pasien kanker kolorektal pada poliklinik Bedah Digestif di RS dr.Cipto Mangunkusumo. Desain studi cross-sectional, digunakan intraclass correlation coeficient ICC untuk menilai test-retest reability. Konsistensi internal dievaluasi menggunakan Cronbach rsquo;s ? coefficient. Validitas konvergen dan diskriminan dianalisa dengan multi-trait scaling. Validitas klinis dievaluasi berdasarkan perbedaan klinis yang telah diketahui sebelumnya menggunakan known-group comparisons. Hasil: Sebanyak limapuluhdua pasien yang berpertisipasi pada penelitian ini. Proses penterjemahan membutuhkan sedikit perubahan akibat adanya perbedaan budaya. Uji test-retest dilakukan pada 17 subjek, yang menunjukan nilai yang dapat diterima 0.67-1.00 . Nilai Cronbach rsquo;s ? coefficient 0,77-0,86, nilai ini melebihi kriteria 0,7. Pada multi-trait scaling analysis menunjukan skala multi-item memenuhi standar validitas konvergen dan diskriminan. Pada uji known group comparison menunjukan kualitas hidup yang berbeda berdasarkan lokasi tumor. Kesimpulan: dibutuhkan adaptsi budaya dalam proses penterjemahan. Kuesioner EORTC QLQ-CR29 yang telah diterjemakan merupakan kuesioner yang valid dan reliabel untuk menilai kualitas hidup pasien kanker kolorektal di Indonesia.

---

Background: Currently in Indonesia the quality of life QoL of colorectal cancer patients is evaluated by many questionnaire. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire ColoRectal 29 EORTC QLQ CR29 , as a standardized objective method to assess QoL of colorectal cancer patients has been widely used in developed country. This research is to prove that EORCT QLQ CR29 is a reliable and valid questionnaire to be used in Indonesia.

Methods: The EORTC QLQ C29 was translated forward and backward into Indonesian language. A pilot study was firstly done then proceed with the main study towards colorectal patients in Digestive Surgery Clinic in Cipto Mangunkusumo Hospital. This is a cross sectional study, intraclass correlation coeficient ICC was used to assess the test retest reability. The Internal consistency reability was estimated using Cronbach rsquo s coefficient. Convergent and discriminant validity was analyzed with multi trait scaling. Clinical validity was assesed in terms of clinical difference using known group comparisons.

Result: Fifty two patients participated in this study. The translation proses require some adjusment due to cultural adaptation. Test retest was administered to 17 patient, showed acceptable reproducibility 0,67 1,00. The Cronbach rsquo s coefficient 0,77 0,86 exceeded the 0,7 criterion and multi trait scaling analysis showed that multi item scales met standards of convergent and discriminant validity. The known group comparisons showed QoL differences between groups of patients based on tumor location.

Conclusion: Some cultural adaptation is needed in the translation process. The translated EORTC QLQ CR29 is a reliable and valid questionnaire for assessing quality of life of colorectal cancer patients in Indonesia."

"Latar belakang: CTC sebagai bagian dari liquid biopsy berperan dalam melakukan monitoring pasien kanker payudara yang menjalani terapi. Adanya CTC menjadi pertanda resistensi terapi dan memengaruhi prognosis pasien. Penelitian ini bertujuan melihat adakah perubahan nilai CTC pada pasien kanker payudara stadium lokal lanjut atau lanjut yang mendapatkan kemoterapi serta melihat perubahan nilai CTC tersebut apakah dipengaruhi oleh usia, status menopause, subtipe, metastasis, dan grade.Metode: Didapatkan 30 sampel pasien kanker payudara stadium lokal lanjut atau lanjut yang akan mendapatkan kemoterapi berbasis Anthracycline dan Taxan. Pre kemoterapi pasien diambil darah perifer dan dilakukan pemeriksaan CTC menggunakan flowcytometry dengan antibodi EpCAM. Pasien lalu menjalani siklus kemoterapi hingga lengkap. Setelah itu pasien kembali diambil darah perifer dan diperiksa nilai CTC post kemoterapi.Hasil: Dari ke 30 sampel, didapatkan mean usia 47,93+7.30. Sebanyak 56,7 (n=17) belum menopause, 43,3% status tumor T3 dan T4, status kelenjar getah bening terbanyak adalah N0 dan N1 (43,3%). Hanya 2 pasien yang ditemukan ada metastasis. 56,7% pasien dengan grade 3, dan subtipe terbanyak adalah luminal B ( 63,4%, n=19). Terdapat 22 pasien (73,3%) dengan ER positif, 14 pasien (46,7%) dengan PR positif. Terdapat 11 pasien (36,7%) dengan Her2 positif dan 21 pasien (70%) dengan Ki67 high proliferation. Hasil CTC pre kemoterapi didapatkan nilai median 1460,50 sedangkan CTC post kemoterapi didapatkan nilai median 415,50 dilakukan uji Wilcoxon dan perbedaan bermakna dengan nilai p=0,002. Analisis multivariat regresi linier dihubungkan antara penurunan nilai CTC terhadap usia, status menopause, subtipe, metastasis, dan grading didapatkan status menopause berhubungan bermakna terhadap perubahan nilai CTC (p<0,05).Kesimpulan: CTC pada pasien kanker payudara stadium lokal lanjut dan lanjut setelah kemoterapi lebih rendah bermakna dibandingkan sebelum kemoterapi. Status menopause memiliki hubungan bermakna terhadap penurunan jumlah CTC setelah kemoterapi pada kanker payudara stadium lokal lanjut dan lanjut

---

.

Background: As part of liquid biopsy, CTCs play a role in monitoring breast cancer patients undergoing therapy. The existence of CTCs is a sign of therapy resistance and affects patient prognosis. This study aims to examine whether there are changes in CTC values in patients with locally advanced or advanced breast cancer, who receive chemotherapy and are influenced by age, menopause status, subtype, metastasis, and grade.

Method: Of the 30 samples of locally advanced or advanced breast cancer patients receiving Anthracycline and Taxan-based chemotherapy were obtained. Pre-chemotherapy, peripheral blood, was drawn and CTCs were examined using flow cytometry with EpCAM antibody. Patients then undergo a complete chemotherapy cycle. After that, the patients were again taken peripheral blood and examined for post-chemotherapy CTC values.

Result: The study was conducted at Cipto Mangunkusumo Hospital, started from December 2022 to December 2023. Of the 30 samples with the mean age was 47,93+7,30. A total of 56,7 (n=17) were not menopause, 43,3% of tumor status with the T3 and T4, and the most common lymph node status with the N0 and N1 (43,3%). Only two patients were found to have metastasis. Then, 56,7% of patients had grade 3, and the most common subtype was luminal B (63,4%, n=19). There were 22 patients (73,3%) with ER positive, 14 patients (46,7%) with PR positive, 11 patients (36,7%) with Her2 positive, and 21 patients (70%) with Ki67 high proliferation. Pre-chemotherapy CTC results obtained a median value of 1460.50, Meanwhile, post-chemotherapy CTC obtained a median value of 415,50. Wilcoxon test was performed and the difference was significant with a value of p = 0,002. Multivariate linear regression analysis was correlated between the decrease in CTC values with age, menopause status, subtype, metastasis, and grading. The menopausal status has a significant association with decrease CTC values (p<0,05).

Conclusion: CTC in locally advanced and advanced breast cancer patients after chemotherapy was significantly lower than before chemotherapy. menopause status has a significant association with decreased CTC values after chemotherapy in locally advanced and advanced breast cancer."

"Kanker merupakan penyakit yang dapat memberikan efek negatif pada fungsi tubuh sehingga mempengaruhi kualitas hidup. Kualitas hidup dapat diukur dengan berbagai macam instrumen. Tujuan: menelaah hasil penelitian mengenai perbandingan skoring kualitas hidup pasien kanker menggunakan EORTC QLQ-C30 dengan FACT-G. Metode : literature review dengan PRISMA checklist sebagai protokol. Analisis bias menggunakan Joanna Briggs Institute (JBI) Critical Appraisal. Pencarian artikel dilakukan Mei-Juli 2020, menggunakan database ClinicalKey, EBSCOhost, Google Scholar, ProQuest, dan PubMed. Dari 1.194 artikel ditemukan, sebanyak 17 artikel sesuai kriteria inklusi. Hasil : skor QoL FACT-G lebih tinggi dibandingkan EORTC QLQ-C30. Selain itu, pada dimensi kualitas hidup dan fisik menunjukkan hubungan yang kuat (r= 0.54-0.76), namun lemah pada dimensi sosial (r=0.00-0.130). Penelitian ini merekomendasikan FACT-G sebagai instrumen yang mengukur QoL secara holistik serta berfokus pada psikososial.

---

Cancer is a disease that can hurt bodily functions that affect the quality of life. Quality of life can be measured by a variety of instruments. Objective: To examine the results of research on the comparison of quality of life scoring in cancer patients using EORTC QLQ-C30 with FACT-G. Methods: A literature review with the PRISMA checklist as a protocol. Biased analysis using the Joanna Briggs Institute (JBI) Critical Appraisal. Search for articles was conducted from May to July 2020, using the ClinicalKey, EBSCOhost, Google Scholar, ProQuest, and PubMed databases. From 1,194 articles found, 17 articles were, according to the inclusion criteria. Result: QoL FACT-G score was higher than the EORTC QLQ-C30. Besides, the quality of life and physical dimensions showed a strong relationship (r = 0.54-0.76), but weak in the social dimension (r = 0.00-0.130). This study recommends FACT-G as an instrument that measures QoL holistically and focuses on psychosocial."

"Kemoterapi sangat penting dalam tatalaksana kanker payudara, namun efek sitotoksiknya seperti leukopenia, dapat meningkatkan risiko infeksi dan menyebabkan penundaan jadwal kemoterapi. Berdasarkan penelitian sebelumnya, terapi akupunktur efektif untuk meminimalkan efek samping kemoterapi termasuk leukopenia. Sebanyak 42 pasien kanker payudara secara acak dibagi menjadi kelompok akupunktur manual dan medikamentosa n = 21 dan kelompok akupunktur manual sham dan medikamentosa n = 21. Titik akupunktur yang dipilih yaitu PC6 Neiguan, LI4 Hegu, ST36 Zusanli dan SP6 Sanyinjiao. Perangsangan dilakukan secara manual selama 20 menit tiap sesi, sebanyak 8 kali. Parameter yang dinilai adalah jumlah leukosit darah dan skor kualitas hidup WHO-QoL BREF. Terdapat perbedaan bermakna terhadap peningkatan skor WHO-QoL BREF sebelum dan sesudah perlakuan akupunktur antara kedua kelompok 9,85 7,065 dan 1,0526 5,778, p = 0,000. Terdapat peningkatan jumlah leukosit darah pada kelompok perlakuan sebelum dan sesudah akupunktur sebesar 0,65 x 103/mL, namun tidak bermakna secara statistik p = 0,955 . Sementara pada kelompok kontrol terdapat penurunan jumlah leukosit darah sebesar 0,7 x 103 mL p = 0,334. Tidak terdapat perbedaan bermakna secara statistik rerata peningkatan jumlah leukosit darah sebelum dan sesudah akupunktur antara dua kelompok 0.475 5.287 and -0.989 3.712, p = 0.326. Terapi akupunktur efektif dalam meningkatkan kualitas hidup pasien kanker payudara dengan kemoterapi, namun dalam meningkatkan jumlah leukosit dibutuhkan terapi yang lebih lama untuk mendapatkan hasil yang lebih maksimal.

---

Chemotherapy is essential in the management of breast cancer, but its cytotoxic effects such as leukopenia, may increase the risk of infection and lead to delay in chemotherapy schedules. Based on previous research, acupuncture therapy is effective to minimize the side effects of chemotherapy including leukopenia. A total of 42 breast cancer patients were randomly divided into groups of manual acupuncture and medicamentous n 21 and the sham manual acupuncture and medicamentous group n 21.

The selected acupuncture points are PC6 Neiguan, LI4 Hegu, ST36 Zusanli and SP6 Sanyinjiao. The stimulation is manually, 20 minutes per session, for 8 times. Parameters assessed were the number of blood leukocytes and quality of life scores WHO QoL BREF . There were significant differences in WHO QoL BREF score before and after acupuncture treatment between the two groups 9.85 7.065 and 1.0526 5.778, p 0.000 . There was an increase in the number of blood leukocytes in the treatment group before and after acupuncture by 0.65 x 103 mL, but not statistically significant p 0.955 . While in the control group there was a decrease in the number of blood leukocytes by 0.7 x 103 mL p 0.334.

There was no statistically significant difference in the mean change of blood leukocyte count before and after acupuncture between two groups 0.475 5.287 and 0.989 3.712, p 0.326. Acupuncture therapy is effective in improving the quality of life of breast cancer patients with chemotherapy, but in increasing the number of leukocytes it takes longer therapy to get maximum results."

"[ABSTRAKLatar Belakang : Pasien gagal jantung mengalami penurunan kapasitas fungsional akibat timbulnya sesak dan kelelahan saat aktifitas. Kondisi ini juga memberikan dampak psikologis berupa depresi dan kecemasan. Masalah fisik dan mental tersebut dapat menurunkan kualitas hidup. Short Form-36 merupakan instrumen yang dapat digunakan untuk menilai kualitas hidup dari aspek fisik dan mental dan bersifat generik.Tujuan: Mengetahui hubungan kapasitas fungsional melalui uji jalan 6 menit dengan kualitas hidup yang dinilai dengan SF-36Metode : Responden penelitian adalah pasien gagal jantung kronis stabil klasifikasi NYHA fungsional kelas II dan III. Setiap responden dianamnesis,dan dilakukan pemeriksaan fisik, kemudian mengisi kuesioner SF-36. Untuk menilai kapasitas fungsional, responden melakukan uji jalan 6 menit pada lintasan sepanjang 30 m.Hasil : Responden pada penelitian ini berjumlah 36 orang. Nilai tengah jarak tempuh pasien gagal jantung klasifikasi NYHA fungsional kelas II dan III masing-masing 333.65m, dan 123.72 m. Jarak tempuh uji jalan 6 menit memiliki hubungan dengan kualitas hidup yang dinilai dengan SF-36 pada domain Fungsi Fisik (r=0.527), Peran Fisik (r=0.459) dan Peran Emosi (r = 0.35).Kesimpulan : Terdapat korelasi sedang antara kapasitas fungsional pasien gagal jantung kronis stabil klasifikasi NYHA fungsional kelas II dan III dengan kualitas hidup pada domain Fungsi Fisik, Peran Fisik dan Peran Emosi.

---

ABSTRACTBackground : Heart failure patients experience reduced functional capicity due to dyspnea and fatigue during activity. The condition also cause psychological problems such as depression and anxiety. Both the mental and physical ailments results in decreased quality of life. The Short Form-36 (SF-36) is a generic assessment tool that can be utilized to measure quality of life from both the physical and mental aspect.Objective : To measure the correlation between the functional capacity measured using the 6-minute walk test and the quality of life measured using the SF-36Methods : The study subjects are chronic stable heart failure patients with New York Heart Association (NYHA) functional class II and III. Each subjects were interviewed, examined, and asked to fill the SF-36 questionnaire. The 6-minute walk test was performed on a 30m long track to measure the finctional capacity.Results : A total of 36 subjects were included in the study. The median for the total distance walked of heart failure patient with NYHA functional class II and III are 333.65m and 123.72 m. The total distance walked in 6-minute walk test and the quality of life measured using the SF-36 have correlation in the domain of Physical Function (r = 0.527), Role-Physical (r = 0.459) and Role-Emotional (r = 0.35)Conclusion : There is a moderate positive correlation between the functional capacity of chronic stable heart failure patient with NYHA functional class II and III with the quality of life in the domain of Physcial Function, Role-Physical and Role-Emotional.;Background : Heart failure patients experience reduced functional capicity due to dyspnea and fatigue during activity. The condition also cause psychological problems such as depression and anxiety. Both the mental and physical ailments results in decreased quality of life. The Short Form-36 (SF-36) is a generic assessment tool that can be utilized to measure quality of life from both the physical and mental aspect.Objective : To measure the correlation between the functional capacity measured using the 6-minute walk test and the quality of life measured using the SF-36Methods : The study subjects are chronic stable heart failure patients with New York Heart Association (NYHA) functional class II and III. Each subjects were interviewed, examined, and asked to fill the SF-36 questionnaire. The 6-minute walk test was performed on a 30m long track to measure the finctional capacity.Results : A total of 36 subjects were included in the study. The median for the total distance walked of heart failure patient with NYHA functional class II and III are 333.65m and 123.72 m. The total distance walked in 6-minute walk test and the quality of life measured using the SF-36 have correlation in the domain of Physical Function (r = 0.527), Role-Physical (r = 0.459) and Role-Emotional (r = 0.35)Conclusion : There is a moderate positive correlation between the functional capacity of chronic stable heart failure patient with NYHA functional class II and III with the quality of life in the domain of Physcial Function, Role-Physical and Role-Emotional., Background : Heart failure patients experience reduced functional capicity due to dyspnea and fatigue during activity. The condition also cause psychological problems such as depression and anxiety. Both the mental and physical ailments results in decreased quality of life. The Short Form-36 (SF-36) is a generic assessment tool that can be utilized to measure quality of life from both the physical and mental aspect.Objective : To measure the correlation between the functional capacity measured using the 6-minute walk test and the quality of life measured using the SF-36Methods : The study subjects are chronic stable heart failure patients with New York Heart Association (NYHA) functional class II and III. Each subjects were interviewed, examined, and asked to fill the SF-36 questionnaire. The 6-minute walk test was performed on a 30m long track to measure the finctional capacity.Results : A total of 36 subjects were included in the study. The median for the total distance walked of heart failure patient with NYHA functional class II and III are 333.65m and 123.72 m. The total distance walked in 6-minute walk test and the quality of life measured using the SF-36 have correlation in the domain of Physical Function (r = 0.527), Role-Physical (r = 0.459) and Role-Emotional (r = 0.35)Conclusion : There is a moderate positive correlation between the functional capacity of chronic stable heart failure patient with NYHA functional class II and III with the quality of life in the domain of Physcial Function, Role-Physical and Role-Emotional.]"

"Angka kejadian kanker stadium III dan IV pada usia dewasa semakin meningkat tiap tahunnya. Penelitian ini bertujuan untuk mengetahui hubungan dukungan keluarga terhadap kualitas hidup anggota keluarganya yang menderita kanker stadium III dan IV di RSKD. Desain penelitian yang digunakan deskriptif korelatif dengan metode analisis univariat dan bivariat. Jumlah sampel 79 responden. Hasil penelitian didapatkan tidak ada hubungan signifikan antara dukungan keluarga terhadap kualitas hidup klien kanker stadium III dan IV. Perawat dalam menghadapi klien sebaiknya menggali koping adaptif, aspek positif, dan aspek spiritualitas klien tidak hanya memberikan dukungan psikologis dalam upaya peningkatan kualitas hidup klien itu sendiri.

---

The incidence of stage III and stage IV cancer adulthood is increasing every year. This study aims to determine the relationship of the family support to quality of life of family members who have stage III and/or stage IV cancer RSKD. The design study is descriptive correlative with univariate and bivariate analysis methods. The number of respondents are 79.

The results showed no significant relationship between family support and the quality of life of clients who have stage III and IV cancer. In dealing with clients, nurses should explore adaptive coping, positive, and spiritual aspects of the client, not only provide psychological support in order to improving quality of life of the client itself."

"Golongan antrasiklin merupakan kemoterapi pilihan pertama untuk penanganan kanker payudara, khususnya pada pasien lanjut usia. Namun beberapa penelitian melaporkan terkait kejadian tidak diharapkan pada penggunaan antrasiklin. Penelitian ini dilakukan bertujuan untuk mengidentifikasi kejadian tidak diharapkan. Selain itu untuk mengetahui hubungan variabel bebas terhadap kejadian tidak diharapkan pada penggunaan rejimen berbasis antrasiklin. Penelitian ini merupakan penelitian observasional dengan rancang penelitian potong lintang (cross-sectional).  Pengambilan sampel dilakukan secara retrospektif, pada pasien lanjut usia (≥60 tahun) di Rumah Sakit Kanker Dharmais. Pengambilan data mulai Januari 2018-Desember 2020. Identifikasi kejadian tidak diharapkan dari penggunaan kemoterapi berbasis antrasiklin menggunakan metode trigger tool khusus untuk pasien kanker. Analisis statistik digunakan untuk memperoleh karakteristik variabel bebas, selain itu untuk mengetahui hubungan variabel bebas terhadap kejadian tidak diharapkan. Pada 107 subjek, sebanyak 71% (n=76 pasien) teridentifikasi dengan trigger tool, seluruh subjek mengalami 122 trigger.rigger pemberian transfusi darah paling banyak ditemukan pada penelitian ini, yaitu pada 39% (n=30 pasien). Netropenia dan anemia merupakan KTD terbanyak yang teridentifikasi pada penggunaan kemoterapi berbasis antrasiklin. Seluruh KTD yang teridentifikasi merupakan kategori E sebanyak 251 kejadian. Pemberian transfusi darah merupakan variabel bebas yang mempunyai hubungan signifikan (p<0,05) dengan kejadian tidak diharapkan dari penggunaan kemoterapi berbasis antrasiklin pada pasien lanjut usia kanker payudara.

---

Anthracycline are the first choice chemotherapy for the treatment of breast cancer, particularly in elderly patients. However, several studies reported adverse events in the treatment of using anthracyclines. This study aims to identify adverse events. Furthermore, to find out more about how independent variables related to adverse event. An observational retrospective study of elderly patient (≥ 60 years) was conducted in a tertiary cancer hospital in Jakarta. Data were collected from January 2018 to December 2020. We used trigger tool specific for cancer patients to identify adverse event during anthracycline base regimen. Independent variables were evaluated in univariate analysis: age, weight loss, marital status, total cumulative dose, polypharmacy, types of anthracycline, metastatic status. Bivariate and multivariate analysis to find out relationship between independent variable and adverse event. In total, 107 subject records were collected and reviewed, there were 71% (n=76 patients) identified with trigger tool. Trigger were totally identified 122 times in 86 medical records. Neutropenia and anemia were the most common adverse events identified in our study. Adverse events with category E identified in all of the subject, as many as 251 events. Blood transfusion had significantly relationship (p<0,05) with adverse events in elderly breast cancer patients."

"Mual muntah pasca kemoterapi merupakan keluhan yang sering timbul pada pasien yang menjalani kemoterapi, hal ini sering menyebabkan turunnya kualitas hidup pasien kanker yang menjalani kemoterapi dengan terapi konvensional. Tujuan dilakukannya penelitian ini untuk melihat peran akupunktur dengan menggunakan press needle dalam mengurangi mual muntah pasca kemoterapi dan memperbaiki kualitas hidup pasien kanker yang menjalani kemoterapi. Uji klinis acak tersamar tunggal dengan kontrol melibatkan 62 subjek kanker payudara yang menjalani kemoterapi intravena yang dibagi secara acak menjadi kelompok press needle dan medikamentosa (n=31), serta kelompok press needle sham dan medikamentosa (n=31). Tindakan akupunktur akan dilakukan 1 minggu sebelum kemoterapi dan pada hari kemoterapi sebelum obat kemoterapi diberikan. Penilaian yang digunakan adalah MAT untuk mual muntah dan FACT-G untuk kualitas hidup. Penilaian FACT-G dilakukan 1 minggu sebelum kemoterapi dan 1 minggu setelah kemoterapi. Penilaian MAT dilakukan pada hari ke-1, hari ke-4 dan hari ke-7 setelah kemoterapi. Hasil penelitian menunjukkan tidak terjadinya mual muntah pada hari ke-4 pada kelompok press needle lebih baik dibandingkan dengan kelompok press needle sham yang secara statistik bermakna dengan OR untuk muntah = 2,968(CI95%: 1,039-8,479) dan OR untuk mual = 10,435 (CI95%: 1,217-89,461). Pada kelompok press needle terjadi peningkatan kualitas hidup yang bermakna (p < 0,001), sedangkan pada kelompok press needle sham terjadi penurunan kualitas hidup yang bermakna (p = 0,001).

---

Nausea vomiting post-chemotherapy is a frequent complaint in patients undergoing chemotherapy, this often leads to a decline in the quality of life of cancer patients undergoing chemotherapy with conventional therapy. The purpose of this study was to see the role of acupuncture by using press needle in reducing post-chemotherapy nausea vomiting and improving the quality of life of cancer patients undergoing chemotherapy. A single blinded, randomized clinical trial involving 62 breast cancer subjects who underwent intravenous chemotherapy were randomly assigned to the press needle and medicinal group (n=31), as well as the press needle sham and medicament groups (n=31). Acupuncture action will be done 1 week before chemotherapy and on the day of chemotherapy before chemotherapy drugs are given. Assessment used is MAT for nausea vomiting and FACT-G for quality of life. FACT-G assessment was performed 1 week before chemotherapy and 1 week after chemotherapy. MAT assessment performed on day 1, day 4 and day 7 after chemotherapy. The results showed no occurrence of nausea of ??vomiting on day 4 in the press needle group better than the press needle sham group which was statistically significant with OR for vomiting = 2.968(CI95:1.039-8.479) and OR for nausea = 10,435 (CI95:1,217-89,461). In the press needle group there was a significant improvement in quality of life p (p<0.001>, whereas in the press needle sham group there was a significant decrease in the quality of life (p=0.001>."